Clinical trials
Inflammatory Bowel Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
277 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 12 |
| 2014 | 17 |
| 2015 | 10 |
| 2016 | 14 |
| 2017 | 20 |
| 2018 | 25 |
| 2019 | 31 |
| 2020 | 24 |
| 2021 | 34 |
| 2022 | 30 |
| 2023 | 29 |
| 2024 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 277 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 23 |
| Mount Sinai Hospital, Canada | 5 |
| Changhai Hospital | 4 |
| Chinese University of Hong Kong | 4 |
| Istituto Clinico Humanitas | 4 |
| Tel-Aviv Sourasky Medical Center | 4 |
| University Hospital Muenster | 4 |
| University of Aarhus | 4 |
| Cedars-Sinai Medical Center | 3 |
| Corporacion Parc Tauli | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Bowel Diseases | 277 |
| Crohn Disease | 86 |
| Colitis, Ulcerative | 78 |
| Colorectal Neoplasms | 12 |
| Irritable Bowel Syndrome | 11 |
| Anxiety Disorders | 7 |
| Fatigue | 6 |
| Anemia, Iron-Deficiency | 5 |
| Arthritis, Rheumatoid | 5 |
| Colonic Neoplasms | 4 |
Trials
Showing 26 to 50 of 277. Each trial links to its page on Pharma Observatory.
177 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.